Efficacy and Safety Study of Talimogene Laherparepvec Compared to Granulocyte Macrophage Colony Stimulating Factor (GM-CSF) in Melanoma

Wits Donald Gordon Clinical Trial Site, Parktown

Medical Oncology Centre of Rosebank, Johannesburg

Hopelands Cancer Centre, Pietermaritzburg

GVI Oncology, Port Elizabeth

GVI Onocology Clinical Trials Unit, Cape Town

Dr. Fourie & Bonnet, Bloemfontein

Columbia Medical University, New York

Mount Sinai School of Medicine, New York

Roswell Park Cancer Institute, Buffalo

St Luke's Hospital & Health Network, Bethlehem

Thomas Jefferson University, Philadelphia

Oncology and Hematology Associates of Southwest Virginia, Inc., Salem

Wake Forest University School of Medicine, Winston-Salem

University of North Carolina At Chapel Hill School of Medicine, Chapel Hill

Duke University Medical Center, Durham

Medical University of South Carolina, Charleston

Institute for Translational Oncology Research, Greenville

Emory University, Atlanta

Baptist Cancer Institute, Jacksonville

MD Anderson Cancer Center Orlando, Orlando

University of Miami, Miami

Mount Sinai Medical Center CCOP, Miami Beach

Palm Beach Cancer Institute, West Palm Beach

H. Lee Moffitt Cancer Center, Tampa

Lakeland Regional Cancer Center, Lakeland

Vanderbilt Ingram Cancer Center, Nashville

James Graham Brown Cancer Center, Louisville

Cleveland Clinic Foundation, Taussig Cancer Center, Cleveland

Gabrail Cancer Center, Canton

Barrett Cancer Center, Cincinnati

Indiana University, Indianapolis

Investigative Clinical Research of Indiana, Indianapolis

University of Iowa Hospitals & Clinics, Iowa City

Aurora/St. Luke's Medical Center, Milwaukee

Hubert H Humphrey Cancer Center, Robbinsdale

Mayo Clinic, Rochester

Cancer Care Center at Lutheran General Hospital, Park Ridge

Rush University Medical Center, Chicago

St. Louis University Hospital, St Louis

Washington University School of Medicine, St Louis

University of Kansas Medical Center, Kansas City

Kansas City Cancer Center, Kansas City

Methodist Estabrook Cancer Center, Omaha

University of Arkansas for Medical Sciences, Little Rock

Mary Crowley Medical Research Center, Dallas

University of Texas - MD Anderson, Houston

Texas Cancer Center, Abilene, Abilene

Texas Oncology, Allison Cancer Center, Midland

University of Colorado Cancer Center, Aurora

Intermountain Medical Center, Murray

Huntsman Cancer Institute, Salt Lake City

University of Arizona Cancer Center, Tucson

New Mexico Cancer Care Alliance, Albuquerque

UCLA Medical Center, Los Angeles

John Wayne Cancer Institute, Santa Monica

University of California San Diego, Moores Cancer Center, La Jolla

San Francisco Oncology Associates, San Francisco

Northern California Melanoma Center, St. Mary's Medical Center, San Francisco

Redwood Regional Medical Group Inc, North Bay Melanoma Program, Sebastopol

Earle A Chiles Research Institute, Providence Cancer Center, Portland

Massachusetts General Hospital Cancer Center, Boston

Mountainside Hospital, Morristown

Rhode Island Hospital, Providence

Cross Cancer Institute, Edmonton

Princess Margaret Hospital, Toronto

Jewish General Hospital, Montreal

University of Pretoria, Pretoria

Mary Potter Oncology Centre, Pretoria

Wilgers Oncology Center, Hatfield

GVI Oncology Centre, Cape Town

University of Birmingham, Birmingham

Addenbrookes Hospital, Cambridge

Broomfield Hospital, Chelmsford

St. James's University Hospital, Leeds

Leicester Royal Infirmary, Leicester

Royal Free Hospital, London

St. George's University of London, London

Royal Marsden Hospital, London

Clatterbridge Centre for Oncology, Metropolitan Borough of Wirral

Freeman Hospital, Newcastle upon Tyne

Nottingham City Hospital, Nottingham

Churchill Hospital, Oxford

Southampton General Hospital, Southampton